Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)

Phase Distribution

Ph early_phase_1
1
50%
Ph not_applicable
1
50%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Terminated(1)
Other(1)

Detailed Status

Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
0.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

suspended150%
terminated150%

Recent Activity

0 active trials
Showing 2 of 2
suspendedearly_phase_1

Body Composition and Sport Performance Among Young Female Soccer Players Using Subdermic Etonogestrel

NCT06775626
terminatednot_applicable

Does Oral Desogestrel Prior to Insertion of the Etonogestrel Subdermal Implant Improve Continuation Rate at One Year?

NCT05174195

Clinical Trials (2)

Showing 2 of 2 trials
NCT06775626Early Phase 1

Body Composition and Sport Performance Among Young Female Soccer Players Using Subdermic Etonogestrel

Suspended
NCT05174195Not Applicable

Does Oral Desogestrel Prior to Insertion of the Etonogestrel Subdermal Implant Improve Continuation Rate at One Year?

Terminated

All 2 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
2